ストックスクリーナーアプリを入手
0.42
4.48%
0.018
前日終値:
$0.402
開ける：
$0.41
24時間の取引高:
54,880
Relative Volume:
0.01
時価総額：
$2.28M
収益：
$502.00K
当期純損益:
$-8.86M
株価収益率:
-0.0741
EPS:
-5.67
ネットキャッシュフロー:
$-10.71M
1週間 パフォーマンス:
-2.33%
1か月 パフォーマンス:
-11.60%
6か月 パフォーマンス:
-37.71%
1年 パフォーマンス:
-92.80%
1日の値動き範囲:
$0.4001
$0.4297
1週間の範囲:
$0.3926
$0.451
52週間の値動き範囲:
$0.373
$7.188
Helius Medical Technologies Inc Stock (HSDT) Company Profile
名前
Helius Medical Technologies Inc
セクター
電話
215-944-6100
住所
642 NEWTOWN YARDLEY ROAD, NEWTOWN, PA
HSDT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HSDT
Helius Medical Technologies Inc
|
0.42 | 2.28M | 502.00K | -8.86M | -10.71M | -5.67 |
|
ABT
Abbott Laboratories
|
130.82 | 226.88B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.36 | 146.96B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
364.50 | 142.81B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
87.63 | 112.37B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
70.91 | 41.85B | 5.72B | 4.17B | 259.90M | 6.97 |
Helius Medical Technologies Inc Stock (HSDT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-03-24 | 開始されました | Noble Capital Markets | Outperform |
Helius Medical Technologies Inc (HSDT) 最新ニュース
Helius Medical Creates Brain-Computer Interface Subsidiary - MPO-mag
SEC Form 424B5 filed by Helius Medical Technologies Inc. - Quantisnow
Helius Medical Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Helius Medical Technologies Inc. (HSDT) reports earnings - Quartz
Chronic Traumatic Encephalopathy Pipeline 2025: MOA, ROA, - openPR
Helius Medical Technologies Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Chronic Traumatic Encephalopathy Treatment Market Size in 7MM - openPR
Helius Medical Technologies Reports Positive Preliminary Results from PoNSTEP Study - MSN
Helius Medical Technologies (HSDT) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Helius Medical Secures First Insurance Reimbursement for PoNS Device - MSN
Helius Medical Unveils Revelation Neuro to Pioneer AI-Powered Neurorehabilitation - MSN
Helius joins BCI landscape with new subsidiary - Yahoo
Helius Medical launches AI-driven BCI subsidiary - Investing.com Australia
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface ('BCI”) Technology Private Subsidiary - The Manila Times
Helius Medical Technologies, Inc. Announces the - GlobeNewswire
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer ... - Bluefield Daily Telegraph
Helius Medical Technologies, Inc. Announces the Establishment of a Wholly Owned Brain Computer Interface (“BCI”) Technology Private Subsidiary - TradingView
Helius Medical's New AI Brain Interface Venture Aims to Transform Neurorehabilitation Without Surgery - StockTitan
Helius Medical Technologies, Inc. Announces First Reimbursement by A Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device - The Manila Times
Helius Medical Technologies, Inc. Announces First - GlobeNewswire
Helius Medical announces first reimbursement for PoNS Device - TipRanks
Major Breakthrough: Anthem BCBS Approves $15,420 Payment for Helius Medical's PoNS Device - StockTitan
Helius Medical Technologies, Inc. (NASDAQ: HSDT) Featured in Coverage of the 37th Annual ROTH Conference - Financial Content
Helius Medical Tech Stock Price, Quotes and Forecasts | NASDAQ:HSDT - Benzinga
Helius Medical Technologies Moves Closer to Medicare Reimbursement, Expands Stroke Program - MSN
Neurology Devices Market Detailed In New Research Report 2025 | - openPR
Research Reports on BELLUS Health Helius Medical Technologies, Resverlogix, and Crescita Therapeutics - ACCESS Newswire
Helius Medical faces Nasdaq delisting over bid price By Investing.com - Investing.com Canada
Helius Medical Technologies (NASDAQ:HSDT) Shares Down 5.8% – What’s Next? - Armenian Reporter
Helius Medical faces Nasdaq delisting over bid price - Investing.com
Helius Medical Technologies IncContinues Non-Compliance With Nasdaq Minimum Bid Price Requirement - Marketscreener.com
Helius Medical Technologies (NASDAQ:HSDT) Trading Down 5.8% – Should You Sell? - Defense World
Enrollment for Helius Stroke Pivotal Study Exceeds Initial Target - Physical Therapy Products
PoNS therapy shows promise for MS gait deficits - MSN
PoNSTEP Study Confirms Long-Term Benefits of PoNS Therapy for MS Patients - MSN
Helius Medical Secures Funds Through Warrant Agreements - TipRanks
HSDTHelius Medical Technologies, Inc. Latest Stock News & Market Updates - StockTitan
Helius Medical Surpasses Enrollment Target for Stroke Program - MSN
Helius Medical Technologies, Inc. Announces Exercise of - GlobeNewswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study - The Manila Times
Helius Medical Technologies, Inc. Announces First Clinical - GlobeNewswire
Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term ... - The Bakersfield Californian
Helius exceeds stroke study enrollment goals By Investing.com - Investing.com Australia
Helius Medical Raises $3.7M Through Warrant Exercise at $0.751, Issues New Warrants - StockTitan
Helius Medical Technologies, Inc. Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $3.7 Million Gross Proceeds Priced At-the-Market - The Manila Times
Helius Medical Technologies Inc (HSDT) 財務データ
収益
当期純利益
現金流量
EPS
0.55%
0.10%
大文字化:
|
ボリューム (24 時間):